Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pear Therapeutics, Inc. - Class A Common Stock (NQ: PEAR ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Apr 18, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Pear Therapeutics, Inc. - Class A Common Stock < Previous 1 2 3 4 5 6 7 Next > Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders January 26, 2023 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List January 18, 2023 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics's Return On Capital Employed Insights December 26, 2022 Via Benzinga Pear Therapeutics to Participate in Citi’s BioTech C-Suite Virtual Fireside Chat Series January 17, 2023 From Pear Therapeutics, Inc. Via Business Wire California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program January 12, 2023 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics January 10, 2023 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States January 04, 2023 From Pear Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's After-Market Session December 26, 2022 Via Benzinga Pear Therapeutics Presents Real-World Clinical Data Assessing Engagement and Abstinence in Patients with Alcohol Use Disorders Using reSET® at AAAP December 15, 2022 From Pear Therapeutics, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Thursday December 22, 2022 Thursday's session saw 329 companies set new 52-week lows. Via Benzinga Pear Therapeutics to Participate in Evercore ISI 5th Annual HealthCONx Conference November 21, 2022 From Pear Therapeutics, Inc. Via Business Wire Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday November 17, 2022 Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. Via Benzinga Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session November 16, 2022 Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session November 16, 2022 Via Benzinga Pear Therapeutics Reports Third Quarter 2022 Results November 14, 2022 From Pear Therapeutics, Inc. Via Business Wire Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday November 15, 2022 Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus... Via Benzinga Earnings Scheduled For November 14, 2022 November 14, 2022 Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. Via Benzinga Pear Therapeutics to Participate in the BTIG Digital Health Forum November 10, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® at ISPOR Europe November 07, 2022 From Pear Therapeutics, Inc. Via Business Wire State of Wisconsin to Provide Access to Prescription Digital Therapeutics to Help Local Communities Fight Against Addiction Crisis November 03, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics to Participate in the Credit Suisse 31st Annual Healthcare Conference November 01, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics to Issue Third Quarter 2022 Financial Results on Monday, November 14, 2022 October 31, 2022 From Pear Therapeutics, Inc. Via Business Wire Avis Budget, Scholastic And Other Big Gainers From Monday October 25, 2022 U.S. stocks closed higher on Monday, with the Dow Jones gaining over 400 points. Here is the list of some big stocks recording gains in the previous session. Via Benzinga Pear Therapeutics Announces Publication of Real-World Data Showing High Rates of Engagement, Retention and Abstinence with reSET® October 24, 2022 From Pear Therapeutics, Inc. Via Business Wire Netflix, Intuitive Surgical And Some Other Big Stocks Moving Higher In Today's Pre-Market Session October 19, 2022 U.S. stock futures traded slightly higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday October 19, 2022 Good morning, investors! We're starting off Wednesday with a breakdown of the biggest pre-market stock movers this morning! Via InvestorPlace Why Olaplex Holdings Shares Are Trading Lower By 42%; Here Are 27 Stocks Moving Premarket October 19, 2022 Gainers SenesTech, Inc. (NASDAQ: SNES) shares rose 65.8% to $0.3847 in pre-market trading after declining over 3% on Tuesday. Via Benzinga Pear Therapeutics to Participate in LifeSci Partners HealthTech Symposium September 13, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference September 07, 2022 From Pear Therapeutics, Inc. Via Business Wire Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday September 12, 2022 Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.